본문 바로가기
KERD
논문KCI 등재

Antinociceptive role of neurotensin receptor 1 in rats with chemotherapy-induced peripheral neuropathy

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

초록

Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a major side effect of anti-cancer drugs. Neurotensin receptors (NTSRs) are widely distributed within the pain circuits in the central nervous system. The purpose of this study was to determine the role of NTSR1 by examining the effects of an NTSR1 agonist in rats with CIPN and investigate the contribution of spinal serotonin receptors to the antinociceptive effect. Methods: Sprague–Dawley rats (weight 150–180 g) were used in this study. CIPN was induced by injecting cisplatin (2 mg/kg) once a day for 4 days. Intrathecal catheters were placed into the subarachnoid space of the CIPN rats. The antiallodynic effects of intrathecally or intraperitoneally administered PD 149163, an NTSR1 agonist, were evaluated. Furthermore, the levels of serotonin in the spinal cord were measured by high-performance liquid chromatography. Results: Intrathecal or intraperitoneal PD 149163 increased the paw withdrawal threshold in CIPN rats. Intrathecal administration of the NTSR1 antagonist SR 48692 suppressed the antinociceptive effect of PD 149163 given via the intrathecal route, but not the antinociceptive effect of intraperitoneally administered PD 149163. Intrathecal administration of dihydroergocristine, a serotonin receptor antagonist, suppressed the antinociceptive effect of intrathecally administered, but not intraperitoneally administered, PD 149163. Injecting cisplatin diminished the serotonin level in the spinal cord, but intrathecal or intraperitoneal administration of PD 149163 did not affect this reduction. Conclusions: NTSR1 played a critical role in modulating CIPN-related pain. Therefore, NTSR1 agonists may be useful therapeutic agents to treat CIPN. In addition, spinal serotonin receptors may be indirectly involved in the effect of NTSR1 agonist.

Abstract

Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a major side effect of anti-cancer drugs. Neurotensin receptors (NTSRs) are widely distributed within the pain circuits in the central nervous system. The purpose of this study was to determine the role of NTSR1 by examining the effects of an NTSR1 agonist in rats with CIPN and investigate the contribution of spinal serotonin receptors to the antinociceptive effect. Methods: Sprague–Dawley rats (weight 150–180 g) were used in this study. CIPN was induced by injecting cisplatin (2 mg/kg) once a day for 4 days. Intrathecal catheters were placed into the subarachnoid space of the CIPN rats. The antiallodynic effects of intrathecally or intraperitoneally administered PD 149163, an NTSR1 agonist, were evaluated. Furthermore, the levels of serotonin in the spinal cord were measured by high-performance liquid chromatography. Results: Intrathecal or intraperitoneal PD 149163 increased the paw withdrawal threshold in CIPN rats. Intrathecal administration of the NTSR1 antagonist SR 48692 suppressed the antinociceptive effect of PD 149163 given via the intrathecal route, but not the antinociceptive effect of intraperitoneally administered PD 149163. Intrathecal administration of dihydroergocristine, a serotonin receptor antagonist, suppressed the antinociceptive effect of intrathecally administered, but not intraperitoneally administered, PD 149163. Injecting cisplatin diminished the serotonin level in the spinal cord, but intrathecal or intraperitoneal administration of PD 149163 did not affect this reduction. Conclusions: NTSR1 played a critical role in modulating CIPN-related pain. Therefore, NTSR1 agonists may be useful therapeutic agents to treat CIPN. In addition, spinal serotonin receptors may be indirectly involved in the effect of NTSR1 agonist.

참고문헌 (30)

  1. Flatters SJL, "Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy(CIPN) : a narrative review", Br J Anaesth, 119, pp.737~749 (2017)
  2. Addington J, "Chemotherapy-induced peripheral neuropathy : an update on the current understanding", F1000Res, 5 (2016)
  3. Fukuda Y, "A mechanistic understanding of axon degeneration in chemotherapy-induced peripheral neuropathy", Front Neurosci, 11, pp.481~ (2017)
  4. Bhandare AM, "Potential analgesic, anti-inflammatory and antioxidant activities of hydroalcoholic extract of Areca catechu L. nut", Food Chem Toxicol, 48, pp.3412~3417 (2010)
  5. Paice JA, "Clinical challenges : chemotherapy-induced peripheral neuropathy", Semin Oncol Nurs, 25(2 Suppl 1), pp.S8~19 (2009)
  6. Hile ES, "Persistent mobility disability after neurotoxic chemotherapy", Phys Ther, 90, pp.1649~1657 (2010)
  7. Carraway R, "The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami", J Biol Chem, 248, pp.6854~6861 (1973)
  8. Jennes L, "Neurotensin : topographical distribution in rat brain by immunohistochemistry", J Comp Neurol, 210, pp.211~224 (1982)
  9. Buhler AV, "Neurotensin activation of the NTR1 on spinally-projecting serotonergic neurons in the rostral ventromedial medulla is antinociceptive", Pain, 114, pp.285~294 (2005)
  10. Buhler AV, "Neurotensin-produced antinociception in the rostral ventromedial medulla is partially mediated by spinal cord norepinephrine", Pain, 135, pp.280~290 (2008)
  11. Petkova-Kirova P, "Stimulation by neurotensin of dopamine and 5-hydroxytryptamine(5-HT)release from rat prefrontal cortex : possible role of NTR1 receptors in neuropsychiatric disorders", Neurochem Int, 53, pp.355~361 (2008)
  12. Roussy G, "Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model", J Neurochem, 105, pp.1100~1114 (2008)
  13. Smith KE, "NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain", Behav Brain Res, 232, pp.93~97 (2012)
  14. Guillemette A, "Intrathecal administration of NTS1 agonists reverses nociceptive behaviors in a rat model of neuropathic pain", Eur J Pain, 16, pp.473~484 (2012)
  15. Bardin L, "The complex role of serotonin and 5-HT receptors in chronic pain", Behav Pharmacol, 22, pp.390~404 (2011)
  16. Ward SJ, "Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A)receptors without diminishing nervous system function or chemotherapy efficacy", Br J Pharmacol, 171, pp.636~645 (2014)
  17. Héaulme M, "Stimulation by neurotensin of(3H)5-hydroxytryptamine(5HT)release from rat frontal cortex slices", Neuropeptides, 32, pp.465~471 (1998)
  18. Jolas T, "Neurotensin excitation of serotonergic neurons in the dorsal raphe nucleus of the rat in vitro", Eur J Neurosci, 8, pp.153~161 (1996)
  19. Hai Lin, "A New Rat Model of Cisplatin-induced Neuropathic Pain", The Korean Journal of Pain, 28(4), pp.236~243 (2015), 대한통증학회
  20. Yaksh TL, "Chronic catheterization of the spinal subarachnoid space", Physiol Behav, 17, pp.1031~1036 (1976)
  21. Yong Ku Han, "Analgesic Effects of Intrathecal Curcumin in the Rat Formalin Test", The Korean Journal of Pain, 25(1), pp.1~6 (2012), 대한통증학회
  22. Kim YO, "Antiallodynic effect of intrathecal Korean Red Ginseng in cisplatin-induced neuropathic pain rats", Pharmacology, 105, pp.173~180 (2020)
  23. Tétreault P, "Spinal NTS2 receptor activation reverses signs of neuropathic pain", FASEB J, 27, pp.3741~3752 (2013)
  24. Roussy G, "Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity", Mol Pain, 5, pp.38~ (2009)
  25. Boules M, "Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neurolepticlike properties", Brain Res, 919, pp.1~11 (2001)
  26. Demeule M, "Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties", J Clin Invest, 124, pp.1199~1213 (2014)
  27. Banks WA, "Permeability of the blood-brain barrier to the neurotensin8-13analog NT1", Brain Res, 695, pp.59~63 (1995)
  28. Hillhouse TM, "Effects of the neurotensin NTS₁ receptor agonist PD 149163 on visual signal detection in rats", Eur J Pharmacol, 721, pp.201~207 (2013)
  29. Clineschmidt BV, "Antinocisponsive effects of neurotensin and neurotensin-related peptides", Ann N Y Acad Sci, 400, pp.283~306 (1982)
  30. Fang FG, "Dose-dependent antinociceptive action of neurotensin microinjected into the rostroventromedial medulla of the rat", Brain Res, 420, pp.171~174 (1987)

관련 논문AI추천

이 간행물의 다른 논문 (14건)